---
title: "Zhengchuan Pharmapack: Expected net profit for the first half of 2025 to decrease by 66.20%-77.47% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248129111.md"
description: "Zhengchuan Pharmapack expects its net profit for the first half of 2025 to decrease by 66.20% year-on-year to 77.47 million yuan, with a net profit attributable to shareholders of the listed company expected to be between 10 million yuan and 15 million yuan, a decrease of 29.3798 million yuan to 34.3798 million yuan compared to the same period last year. The net profit after deducting non-recurring gains and losses is expected to be between 7 million yuan and 10.5 million yuan, a year-on-year decrease of 74.25% to 82.83%"
datetime: "2025-07-11T09:09:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248129111.md)
  - [en](https://longbridge.com/en/news/248129111.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248129111.md)
generator: "portal-rs"
---

# Zhengchuan Pharmapack: Expected net profit for the first half of 2025 to decrease by 66.20%-77.47% year-on-year

Zhengchuan Pharmapack announced that it expects to achieve a net profit attributable to shareholders of the listed company of between 10 million and 15 million yuan for the first half of 2025, a decrease of 29.3798 million to 34.3798 million yuan compared to the same period last year, representing a year-on-year decrease of 66.20% to 77.47%. It is expected that the net profit attributable to shareholders of the listed company, after deducting non-recurring gains and losses, will be between 7 million and 10.5 million yuan for the first half of 2025, a decrease of 30.2705 million to 33.7705 million yuan compared to the same period last year, representing a year-on-year decrease of 74.25% to 82.83%

### Related Stocks

- [603976.CN](https://longbridge.com/en/quote/603976.CN.md)

## Related News & Research

- [Underlying Inflation Hits Lowest Since 2021: Why Markets Bet On Fed Hikes?](https://longbridge.com/en/news/298745975.md)
- [Havas, linked to Louis Hachette director Yannick Bolloré, purchases EUR 5.31 million of Louis Hachette Group shares](https://longbridge.com/en/news/298621675.md)
- [ANALYSIS-Edgy bond investors unconsoled by Bessent's big buyback](https://longbridge.com/en/news/298749268.md)
- [Climeworks says upgraded Mammoth units more than double CO₂ capture performance](https://longbridge.com/en/news/298546691.md)
- [M Stanley: Capital Injection Dilution for ICBC Milder Than Forecast; ABC Equity Dilution In Line](https://longbridge.com/en/news/298162976.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**